Qualigen Therapeutics Received Nasdaq Notice Of A Delisting Determination
QIAGEN NV +0.21% Pre
QIAGEN NV QGEN | 42.21 42.18 | +0.21% -0.07% Pre |
Qualigen Therapeutics, Inc. (("Qualigen" or "the Company, NASDAQ:QLGN), announced today that on May 23, 2024, it received written notice (the "Delist Notice") from The Nasdaq Stock Market ("Nasdaq") indicating the Company's continued non-compliance with the minimum bid price requirement, pursuant to Listing Rule 5550(b)(2).